nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS1—kidney cancer	0.313	0.636	CbGaD
Etodolac—PTGS2—kidney cancer	0.179	0.364	CbGaD
Etodolac—UGT1A9—Sorafenib—kidney cancer	0.0766	0.491	CbGbCtD
Etodolac—ALB—Erlotinib—kidney cancer	0.0292	0.187	CbGbCtD
Etodolac—CYP2C9—Capecitabine—kidney cancer	0.023	0.148	CbGbCtD
Etodolac—CYP2C9—Paclitaxel—kidney cancer	0.0144	0.0924	CbGbCtD
Etodolac—CYP2C9—Sorafenib—kidney cancer	0.0128	0.082	CbGbCtD
Etodolac—UGT1A10—renal system—kidney cancer	0.00454	0.133	CbGeAlD
Etodolac—UGT1A10—kidney—kidney cancer	0.00439	0.128	CbGeAlD
Etodolac—PTGS2—nephron—kidney cancer	0.00292	0.0853	CbGeAlD
Etodolac—RXRA—renal system—kidney cancer	0.00271	0.0791	CbGeAlD
Etodolac—CYP2C9—urine—kidney cancer	0.00269	0.0784	CbGeAlD
Etodolac—RXRA—kidney—kidney cancer	0.00262	0.0765	CbGeAlD
Etodolac—UGT1A9—renal system—kidney cancer	0.00228	0.0666	CbGeAlD
Etodolac—UGT1A9—kidney—kidney cancer	0.0022	0.0644	CbGeAlD
Etodolac—SLC22A6—nephron tubule—kidney cancer	0.00186	0.0542	CbGeAlD
Etodolac—UGT2B7—renal system—kidney cancer	0.00184	0.0537	CbGeAlD
Etodolac—UGT2B7—kidney—kidney cancer	0.00178	0.0519	CbGeAlD
Etodolac—SLC22A6—cortex of kidney—kidney cancer	0.00159	0.0464	CbGeAlD
Etodolac—PTGS1—renal system—kidney cancer	0.0006	0.0175	CbGeAlD
Etodolac—PTGS1—kidney—kidney cancer	0.00058	0.0169	CbGeAlD
Etodolac—PTGS2—renal system—kidney cancer	0.000573	0.0167	CbGeAlD
Etodolac—PTGS2—kidney—kidney cancer	0.000554	0.0162	CbGeAlD
Etodolac—PTGS1—cardiac atrium—kidney cancer	0.000537	0.0157	CbGeAlD
Etodolac—Palpitations—Paclitaxel—kidney cancer	0.000116	0.000521	CcSEcCtD
Etodolac—Insomnia—Gemcitabine—kidney cancer	0.000116	0.00052	CcSEcCtD
Etodolac—Headache—Erlotinib—kidney cancer	0.000116	0.000518	CcSEcCtD
Etodolac—Tinnitus—Capecitabine—kidney cancer	0.000116	0.000518	CcSEcCtD
Etodolac—Loss of consciousness—Paclitaxel—kidney cancer	0.000116	0.000518	CcSEcCtD
Etodolac—Pain—Vincristine—kidney cancer	0.000116	0.000518	CcSEcCtD
Etodolac—Constipation—Vincristine—kidney cancer	0.000116	0.000518	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000116	0.000518	CcSEcCtD
Etodolac—Paraesthesia—Gemcitabine—kidney cancer	0.000115	0.000516	CcSEcCtD
Etodolac—Flushing—Capecitabine—kidney cancer	0.000115	0.000516	CcSEcCtD
Etodolac—Asthenia—Sunitinib—kidney cancer	0.000115	0.000514	CcSEcCtD
Etodolac—Dyspnoea—Gemcitabine—kidney cancer	0.000114	0.000512	CcSEcCtD
Etodolac—Nausea—Vinblastine—kidney cancer	0.000114	0.000511	CcSEcCtD
Etodolac—Somnolence—Gemcitabine—kidney cancer	0.000114	0.000511	CcSEcCtD
Etodolac—Convulsion—Paclitaxel—kidney cancer	0.000114	0.000511	CcSEcCtD
Etodolac—Nausea—Everolimus—kidney cancer	0.000114	0.000509	CcSEcCtD
Etodolac—Diarrhoea—Sorafenib—kidney cancer	0.000114	0.000509	CcSEcCtD
Etodolac—Hypertension—Paclitaxel—kidney cancer	0.000114	0.000509	CcSEcCtD
Etodolac—Pruritus—Sunitinib—kidney cancer	0.000113	0.000507	CcSEcCtD
Etodolac—Arthralgia—Paclitaxel—kidney cancer	0.000112	0.000502	CcSEcCtD
Etodolac—Myalgia—Paclitaxel—kidney cancer	0.000112	0.000502	CcSEcCtD
Etodolac—Anxiety—Paclitaxel—kidney cancer	0.000112	0.0005	CcSEcCtD
Etodolac—Decreased appetite—Gemcitabine—kidney cancer	0.000111	0.0005	CcSEcCtD
Etodolac—Hypersensitivity—Dactinomycin—kidney cancer	0.000111	0.0005	CcSEcCtD
Etodolac—Chills—Capecitabine—kidney cancer	0.000111	0.000499	CcSEcCtD
Etodolac—Arrhythmia—Capecitabine—kidney cancer	0.000111	0.000497	CcSEcCtD
Etodolac—Discomfort—Paclitaxel—kidney cancer	0.000111	0.000496	CcSEcCtD
Etodolac—Fatigue—Gemcitabine—kidney cancer	0.000111	0.000495	CcSEcCtD
Etodolac—Gastrointestinal pain—Vincristine—kidney cancer	0.000111	0.000495	CcSEcCtD
Etodolac—Dizziness—Sorafenib—kidney cancer	0.00011	0.000492	CcSEcCtD
Etodolac—Pain—Gemcitabine—kidney cancer	0.00011	0.000491	CcSEcCtD
Etodolac—Constipation—Gemcitabine—kidney cancer	0.00011	0.000491	CcSEcCtD
Etodolac—Nausea—Erlotinib—kidney cancer	0.00011	0.000491	CcSEcCtD
Etodolac—Alopecia—Capecitabine—kidney cancer	0.00011	0.000491	CcSEcCtD
Etodolac—Dry mouth—Paclitaxel—kidney cancer	0.00011	0.000491	CcSEcCtD
Etodolac—Diarrhoea—Sunitinib—kidney cancer	0.000109	0.00049	CcSEcCtD
Etodolac—Asthenia—Dactinomycin—kidney cancer	0.000109	0.000486	CcSEcCtD
Etodolac—Confusional state—Paclitaxel—kidney cancer	0.000108	0.000485	CcSEcCtD
Etodolac—Oedema—Paclitaxel—kidney cancer	0.000107	0.000481	CcSEcCtD
Etodolac—Anaphylactic shock—Paclitaxel—kidney cancer	0.000107	0.000481	CcSEcCtD
Etodolac—Body temperature increased—Vincristine—kidney cancer	0.000107	0.000479	CcSEcCtD
Etodolac—Abdominal pain—Vincristine—kidney cancer	0.000107	0.000479	CcSEcCtD
Etodolac—Infection—Paclitaxel—kidney cancer	0.000107	0.000478	CcSEcCtD
Etodolac—Flatulence—Capecitabine—kidney cancer	0.000106	0.000477	CcSEcCtD
Etodolac—Dysgeusia—Capecitabine—kidney cancer	0.000106	0.000474	CcSEcCtD
Etodolac—Dizziness—Sunitinib—kidney cancer	0.000106	0.000474	CcSEcCtD
Etodolac—Feeling abnormal—Gemcitabine—kidney cancer	0.000106	0.000474	CcSEcCtD
Etodolac—Shock—Paclitaxel—kidney cancer	0.000106	0.000473	CcSEcCtD
Etodolac—Vomiting—Sorafenib—kidney cancer	0.000106	0.000473	CcSEcCtD
Etodolac—Abdominal pain upper—Doxorubicin—kidney cancer	0.000106	0.000473	CcSEcCtD
Etodolac—Thrombocytopenia—Paclitaxel—kidney cancer	0.000105	0.000471	CcSEcCtD
Etodolac—Tachycardia—Paclitaxel—kidney cancer	0.000105	0.00047	CcSEcCtD
Etodolac—Rash—Sorafenib—kidney cancer	0.000105	0.000469	CcSEcCtD
Etodolac—Dermatitis—Sorafenib—kidney cancer	0.000105	0.000469	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000104	0.000466	CcSEcCtD
Etodolac—Headache—Sorafenib—kidney cancer	0.000104	0.000466	CcSEcCtD
Etodolac—Hyperhidrosis—Paclitaxel—kidney cancer	0.000104	0.000465	CcSEcCtD
Etodolac—Diarrhoea—Dactinomycin—kidney cancer	0.000104	0.000464	CcSEcCtD
Etodolac—Anorexia—Paclitaxel—kidney cancer	0.000102	0.000459	CcSEcCtD
Etodolac—Gastritis—Doxorubicin—kidney cancer	0.000102	0.000458	CcSEcCtD
Etodolac—Vision blurred—Capecitabine—kidney cancer	0.000102	0.000456	CcSEcCtD
Etodolac—Vomiting—Sunitinib—kidney cancer	0.000102	0.000455	CcSEcCtD
Etodolac—Body temperature increased—Gemcitabine—kidney cancer	0.000101	0.000454	CcSEcCtD
Etodolac—Tremor—Capecitabine—kidney cancer	0.000101	0.000453	CcSEcCtD
Etodolac—Rash—Sunitinib—kidney cancer	0.000101	0.000452	CcSEcCtD
Etodolac—Dermatitis—Sunitinib—kidney cancer	0.000101	0.000451	CcSEcCtD
Etodolac—Abdominal distension—Doxorubicin—kidney cancer	0.000101	0.000451	CcSEcCtD
Etodolac—Hypotension—Paclitaxel—kidney cancer	0.0001	0.00045	CcSEcCtD
Etodolac—Ill-defined disorder—Capecitabine—kidney cancer	0.0001	0.000449	CcSEcCtD
Etodolac—Headache—Sunitinib—kidney cancer	0.0001	0.000449	CcSEcCtD
Etodolac—Asthma—Doxorubicin—kidney cancer	9.99e-05	0.000448	CcSEcCtD
Etodolac—Anaemia—Capecitabine—kidney cancer	9.98e-05	0.000447	CcSEcCtD
Etodolac—Hypersensitivity—Vincristine—kidney cancer	9.96e-05	0.000446	CcSEcCtD
Etodolac—Eosinophilia—Doxorubicin—kidney cancer	9.89e-05	0.000443	CcSEcCtD
Etodolac—Nausea—Sorafenib—kidney cancer	9.87e-05	0.000442	CcSEcCtD
Etodolac—Pancreatitis—Doxorubicin—kidney cancer	9.79e-05	0.000439	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Paclitaxel—kidney cancer	9.78e-05	0.000438	CcSEcCtD
Etodolac—Malaise—Capecitabine—kidney cancer	9.74e-05	0.000436	CcSEcCtD
Etodolac—Insomnia—Paclitaxel—kidney cancer	9.71e-05	0.000435	CcSEcCtD
Etodolac—Vertigo—Capecitabine—kidney cancer	9.7e-05	0.000435	CcSEcCtD
Etodolac—Asthenia—Vincristine—kidney cancer	9.7e-05	0.000435	CcSEcCtD
Etodolac—Syncope—Capecitabine—kidney cancer	9.68e-05	0.000434	CcSEcCtD
Etodolac—Leukopenia—Capecitabine—kidney cancer	9.67e-05	0.000433	CcSEcCtD
Etodolac—Paraesthesia—Paclitaxel—kidney cancer	9.64e-05	0.000432	CcSEcCtD
Etodolac—Vomiting—Dactinomycin—kidney cancer	9.62e-05	0.000431	CcSEcCtD
Etodolac—Bronchitis—Doxorubicin—kidney cancer	9.61e-05	0.00043	CcSEcCtD
Etodolac—Dyspnoea—Paclitaxel—kidney cancer	9.57e-05	0.000429	CcSEcCtD
Etodolac—Somnolence—Paclitaxel—kidney cancer	9.55e-05	0.000428	CcSEcCtD
Etodolac—Palpitations—Capecitabine—kidney cancer	9.54e-05	0.000428	CcSEcCtD
Etodolac—Rash—Dactinomycin—kidney cancer	9.54e-05	0.000428	CcSEcCtD
Etodolac—Nausea—Sunitinib—kidney cancer	9.49e-05	0.000425	CcSEcCtD
Etodolac—Loss of consciousness—Capecitabine—kidney cancer	9.49e-05	0.000425	CcSEcCtD
Etodolac—Pancytopenia—Doxorubicin—kidney cancer	9.49e-05	0.000425	CcSEcCtD
Etodolac—Dyspepsia—Paclitaxel—kidney cancer	9.45e-05	0.000424	CcSEcCtD
Etodolac—Dysuria—Doxorubicin—kidney cancer	9.34e-05	0.000419	CcSEcCtD
Etodolac—Neutropenia—Doxorubicin—kidney cancer	9.34e-05	0.000419	CcSEcCtD
Etodolac—Decreased appetite—Paclitaxel—kidney cancer	9.33e-05	0.000418	CcSEcCtD
Etodolac—Hypertension—Capecitabine—kidney cancer	9.32e-05	0.000418	CcSEcCtD
Etodolac—Fatigue—Paclitaxel—kidney cancer	9.26e-05	0.000415	CcSEcCtD
Etodolac—Diarrhoea—Vincristine—kidney cancer	9.25e-05	0.000415	CcSEcCtD
Etodolac—Pollakiuria—Doxorubicin—kidney cancer	9.23e-05	0.000413	CcSEcCtD
Etodolac—Asthenia—Gemcitabine—kidney cancer	9.2e-05	0.000412	CcSEcCtD
Etodolac—Myalgia—Capecitabine—kidney cancer	9.19e-05	0.000412	CcSEcCtD
Etodolac—Arthralgia—Capecitabine—kidney cancer	9.19e-05	0.000412	CcSEcCtD
Etodolac—Pain—Paclitaxel—kidney cancer	9.18e-05	0.000411	CcSEcCtD
Etodolac—Constipation—Paclitaxel—kidney cancer	9.18e-05	0.000411	CcSEcCtD
Etodolac—Anxiety—Capecitabine—kidney cancer	9.16e-05	0.00041	CcSEcCtD
Etodolac—Photosensitivity reaction—Doxorubicin—kidney cancer	9.12e-05	0.000409	CcSEcCtD
Etodolac—Discomfort—Capecitabine—kidney cancer	9.08e-05	0.000407	CcSEcCtD
Etodolac—Pruritus—Gemcitabine—kidney cancer	9.07e-05	0.000407	CcSEcCtD
Etodolac—Hyperglycaemia—Doxorubicin—kidney cancer	9.01e-05	0.000404	CcSEcCtD
Etodolac—Dry mouth—Capecitabine—kidney cancer	8.99e-05	0.000403	CcSEcCtD
Etodolac—Nausea—Dactinomycin—kidney cancer	8.99e-05	0.000403	CcSEcCtD
Etodolac—Pneumonia—Doxorubicin—kidney cancer	8.96e-05	0.000401	CcSEcCtD
Etodolac—Dizziness—Vincristine—kidney cancer	8.94e-05	0.000401	CcSEcCtD
Etodolac—Confusional state—Capecitabine—kidney cancer	8.89e-05	0.000398	CcSEcCtD
Etodolac—Feeling abnormal—Paclitaxel—kidney cancer	8.85e-05	0.000397	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	8.83e-05	0.000396	CcSEcCtD
Etodolac—Oedema—Capecitabine—kidney cancer	8.81e-05	0.000395	CcSEcCtD
Etodolac—Gastrointestinal pain—Paclitaxel—kidney cancer	8.78e-05	0.000393	CcSEcCtD
Etodolac—Diarrhoea—Gemcitabine—kidney cancer	8.78e-05	0.000393	CcSEcCtD
Etodolac—Renal failure—Doxorubicin—kidney cancer	8.76e-05	0.000392	CcSEcCtD
Etodolac—Infection—Capecitabine—kidney cancer	8.75e-05	0.000392	CcSEcCtD
Etodolac—Stomatitis—Doxorubicin—kidney cancer	8.68e-05	0.000389	CcSEcCtD
Etodolac—Jaundice—Doxorubicin—kidney cancer	8.68e-05	0.000389	CcSEcCtD
Etodolac—Shock—Capecitabine—kidney cancer	8.67e-05	0.000388	CcSEcCtD
Etodolac—Conjunctivitis—Doxorubicin—kidney cancer	8.66e-05	0.000388	CcSEcCtD
Etodolac—Thrombocytopenia—Capecitabine—kidney cancer	8.63e-05	0.000387	CcSEcCtD
Etodolac—Tachycardia—Capecitabine—kidney cancer	8.6e-05	0.000385	CcSEcCtD
Etodolac—Vomiting—Vincristine—kidney cancer	8.6e-05	0.000385	CcSEcCtD
Etodolac—Sweating—Doxorubicin—kidney cancer	8.54e-05	0.000383	CcSEcCtD
Etodolac—Urticaria—Paclitaxel—kidney cancer	8.53e-05	0.000382	CcSEcCtD
Etodolac—Rash—Vincristine—kidney cancer	8.52e-05	0.000382	CcSEcCtD
Etodolac—Hyperhidrosis—Capecitabine—kidney cancer	8.52e-05	0.000382	CcSEcCtD
Etodolac—Dermatitis—Vincristine—kidney cancer	8.52e-05	0.000382	CcSEcCtD
Etodolac—Haematuria—Doxorubicin—kidney cancer	8.49e-05	0.000381	CcSEcCtD
Etodolac—Abdominal pain—Paclitaxel—kidney cancer	8.49e-05	0.00038	CcSEcCtD
Etodolac—Body temperature increased—Paclitaxel—kidney cancer	8.49e-05	0.00038	CcSEcCtD
Etodolac—Headache—Vincristine—kidney cancer	8.47e-05	0.00038	CcSEcCtD
Etodolac—Anorexia—Capecitabine—kidney cancer	8.4e-05	0.000376	CcSEcCtD
Etodolac—Sinusitis—Doxorubicin—kidney cancer	8.36e-05	0.000374	CcSEcCtD
Etodolac—Agranulocytosis—Doxorubicin—kidney cancer	8.31e-05	0.000372	CcSEcCtD
Etodolac—Hypotension—Capecitabine—kidney cancer	8.23e-05	0.000369	CcSEcCtD
Etodolac—Vomiting—Gemcitabine—kidney cancer	8.15e-05	0.000365	CcSEcCtD
Etodolac—Rash—Gemcitabine—kidney cancer	8.09e-05	0.000362	CcSEcCtD
Etodolac—Dermatitis—Gemcitabine—kidney cancer	8.08e-05	0.000362	CcSEcCtD
Etodolac—Haemoglobin—Doxorubicin—kidney cancer	8.04e-05	0.00036	CcSEcCtD
Etodolac—Headache—Gemcitabine—kidney cancer	8.03e-05	0.00036	CcSEcCtD
Etodolac—Nausea—Vincristine—kidney cancer	8.03e-05	0.00036	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.03e-05	0.00036	CcSEcCtD
Etodolac—Rhinitis—Doxorubicin—kidney cancer	8.02e-05	0.000359	CcSEcCtD
Etodolac—Hepatitis—Doxorubicin—kidney cancer	8e-05	0.000358	CcSEcCtD
Etodolac—Haemorrhage—Doxorubicin—kidney cancer	8e-05	0.000358	CcSEcCtD
Etodolac—Insomnia—Capecitabine—kidney cancer	7.97e-05	0.000357	CcSEcCtD
Etodolac—Pharyngitis—Doxorubicin—kidney cancer	7.94e-05	0.000356	CcSEcCtD
Etodolac—Paraesthesia—Capecitabine—kidney cancer	7.91e-05	0.000355	CcSEcCtD
Etodolac—Hypersensitivity—Paclitaxel—kidney cancer	7.91e-05	0.000355	CcSEcCtD
Etodolac—Dyspnoea—Capecitabine—kidney cancer	7.86e-05	0.000352	CcSEcCtD
Etodolac—Dyspepsia—Capecitabine—kidney cancer	7.76e-05	0.000348	CcSEcCtD
Etodolac—Visual impairment—Doxorubicin—kidney cancer	7.71e-05	0.000345	CcSEcCtD
Etodolac—Asthenia—Paclitaxel—kidney cancer	7.7e-05	0.000345	CcSEcCtD
Etodolac—Decreased appetite—Capecitabine—kidney cancer	7.66e-05	0.000343	CcSEcCtD
Etodolac—Nausea—Gemcitabine—kidney cancer	7.62e-05	0.000341	CcSEcCtD
Etodolac—Fatigue—Capecitabine—kidney cancer	7.6e-05	0.00034	CcSEcCtD
Etodolac—Pruritus—Paclitaxel—kidney cancer	7.6e-05	0.00034	CcSEcCtD
Etodolac—Erythema multiforme—Doxorubicin—kidney cancer	7.56e-05	0.000339	CcSEcCtD
Etodolac—Constipation—Capecitabine—kidney cancer	7.54e-05	0.000338	CcSEcCtD
Etodolac—Pain—Capecitabine—kidney cancer	7.54e-05	0.000338	CcSEcCtD
Etodolac—Tinnitus—Doxorubicin—kidney cancer	7.45e-05	0.000334	CcSEcCtD
Etodolac—Flushing—Doxorubicin—kidney cancer	7.42e-05	0.000333	CcSEcCtD
Etodolac—Diarrhoea—Paclitaxel—kidney cancer	7.35e-05	0.000329	CcSEcCtD
Etodolac—Feeling abnormal—Capecitabine—kidney cancer	7.26e-05	0.000325	CcSEcCtD
Etodolac—Gastrointestinal pain—Capecitabine—kidney cancer	7.21e-05	0.000323	CcSEcCtD
Etodolac—Chills—Doxorubicin—kidney cancer	7.17e-05	0.000321	CcSEcCtD
Etodolac—Arrhythmia—Doxorubicin—kidney cancer	7.14e-05	0.00032	CcSEcCtD
Etodolac—Dizziness—Paclitaxel—kidney cancer	7.1e-05	0.000318	CcSEcCtD
Etodolac—Alopecia—Doxorubicin—kidney cancer	7.07e-05	0.000317	CcSEcCtD
Etodolac—Urticaria—Capecitabine—kidney cancer	7e-05	0.000314	CcSEcCtD
Etodolac—Body temperature increased—Capecitabine—kidney cancer	6.97e-05	0.000312	CcSEcCtD
Etodolac—Abdominal pain—Capecitabine—kidney cancer	6.97e-05	0.000312	CcSEcCtD
Etodolac—Flatulence—Doxorubicin—kidney cancer	6.86e-05	0.000307	CcSEcCtD
Etodolac—Tension—Doxorubicin—kidney cancer	6.83e-05	0.000306	CcSEcCtD
Etodolac—Vomiting—Paclitaxel—kidney cancer	6.83e-05	0.000306	CcSEcCtD
Etodolac—Dysgeusia—Doxorubicin—kidney cancer	6.82e-05	0.000305	CcSEcCtD
Etodolac—Rash—Paclitaxel—kidney cancer	6.77e-05	0.000303	CcSEcCtD
Etodolac—Dermatitis—Paclitaxel—kidney cancer	6.76e-05	0.000303	CcSEcCtD
Etodolac—Nervousness—Doxorubicin—kidney cancer	6.76e-05	0.000303	CcSEcCtD
Etodolac—Headache—Paclitaxel—kidney cancer	6.73e-05	0.000301	CcSEcCtD
Etodolac—Vision blurred—Doxorubicin—kidney cancer	6.56e-05	0.000294	CcSEcCtD
Etodolac—Hypersensitivity—Capecitabine—kidney cancer	6.49e-05	0.000291	CcSEcCtD
Etodolac—Ill-defined disorder—Doxorubicin—kidney cancer	6.46e-05	0.000289	CcSEcCtD
Etodolac—Anaemia—Doxorubicin—kidney cancer	6.43e-05	0.000288	CcSEcCtD
Etodolac—Nausea—Paclitaxel—kidney cancer	6.38e-05	0.000286	CcSEcCtD
Etodolac—Asthenia—Capecitabine—kidney cancer	6.32e-05	0.000283	CcSEcCtD
Etodolac—Malaise—Doxorubicin—kidney cancer	6.28e-05	0.000281	CcSEcCtD
Etodolac—Vertigo—Doxorubicin—kidney cancer	6.25e-05	0.00028	CcSEcCtD
Etodolac—Syncope—Doxorubicin—kidney cancer	6.24e-05	0.00028	CcSEcCtD
Etodolac—Pruritus—Capecitabine—kidney cancer	6.23e-05	0.000279	CcSEcCtD
Etodolac—Leukopenia—Doxorubicin—kidney cancer	6.23e-05	0.000279	CcSEcCtD
Etodolac—Palpitations—Doxorubicin—kidney cancer	6.15e-05	0.000276	CcSEcCtD
Etodolac—Loss of consciousness—Doxorubicin—kidney cancer	6.12e-05	0.000274	CcSEcCtD
Etodolac—Convulsion—Doxorubicin—kidney cancer	6.03e-05	0.00027	CcSEcCtD
Etodolac—Diarrhoea—Capecitabine—kidney cancer	6.03e-05	0.00027	CcSEcCtD
Etodolac—Hypertension—Doxorubicin—kidney cancer	6.01e-05	0.000269	CcSEcCtD
Etodolac—Myalgia—Doxorubicin—kidney cancer	5.93e-05	0.000266	CcSEcCtD
Etodolac—Arthralgia—Doxorubicin—kidney cancer	5.93e-05	0.000266	CcSEcCtD
Etodolac—Anxiety—Doxorubicin—kidney cancer	5.91e-05	0.000265	CcSEcCtD
Etodolac—Discomfort—Doxorubicin—kidney cancer	5.85e-05	0.000262	CcSEcCtD
Etodolac—Dizziness—Capecitabine—kidney cancer	5.83e-05	0.000261	CcSEcCtD
Etodolac—Dry mouth—Doxorubicin—kidney cancer	5.8e-05	0.00026	CcSEcCtD
Etodolac—Confusional state—Doxorubicin—kidney cancer	5.73e-05	0.000257	CcSEcCtD
Etodolac—Anaphylactic shock—Doxorubicin—kidney cancer	5.68e-05	0.000255	CcSEcCtD
Etodolac—Oedema—Doxorubicin—kidney cancer	5.68e-05	0.000255	CcSEcCtD
Etodolac—Infection—Doxorubicin—kidney cancer	5.64e-05	0.000253	CcSEcCtD
Etodolac—Vomiting—Capecitabine—kidney cancer	5.6e-05	0.000251	CcSEcCtD
Etodolac—Shock—Doxorubicin—kidney cancer	5.59e-05	0.00025	CcSEcCtD
Etodolac—Thrombocytopenia—Doxorubicin—kidney cancer	5.56e-05	0.000249	CcSEcCtD
Etodolac—Rash—Capecitabine—kidney cancer	5.56e-05	0.000249	CcSEcCtD
Etodolac—Dermatitis—Capecitabine—kidney cancer	5.55e-05	0.000249	CcSEcCtD
Etodolac—Tachycardia—Doxorubicin—kidney cancer	5.54e-05	0.000248	CcSEcCtD
Etodolac—Headache—Capecitabine—kidney cancer	5.52e-05	0.000247	CcSEcCtD
Etodolac—Hyperhidrosis—Doxorubicin—kidney cancer	5.49e-05	0.000246	CcSEcCtD
Etodolac—Anorexia—Doxorubicin—kidney cancer	5.41e-05	0.000243	CcSEcCtD
Etodolac—Hypotension—Doxorubicin—kidney cancer	5.31e-05	0.000238	CcSEcCtD
Etodolac—Nausea—Capecitabine—kidney cancer	5.23e-05	0.000235	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.18e-05	0.000232	CcSEcCtD
Etodolac—Insomnia—Doxorubicin—kidney cancer	5.14e-05	0.00023	CcSEcCtD
Etodolac—Paraesthesia—Doxorubicin—kidney cancer	5.1e-05	0.000229	CcSEcCtD
Etodolac—Dyspnoea—Doxorubicin—kidney cancer	5.06e-05	0.000227	CcSEcCtD
Etodolac—Somnolence—Doxorubicin—kidney cancer	5.05e-05	0.000226	CcSEcCtD
Etodolac—Dyspepsia—Doxorubicin—kidney cancer	5e-05	0.000224	CcSEcCtD
Etodolac—Decreased appetite—Doxorubicin—kidney cancer	4.94e-05	0.000221	CcSEcCtD
Etodolac—Fatigue—Doxorubicin—kidney cancer	4.9e-05	0.000219	CcSEcCtD
Etodolac—Constipation—Doxorubicin—kidney cancer	4.86e-05	0.000218	CcSEcCtD
Etodolac—Pain—Doxorubicin—kidney cancer	4.86e-05	0.000218	CcSEcCtD
Etodolac—Feeling abnormal—Doxorubicin—kidney cancer	4.68e-05	0.00021	CcSEcCtD
Etodolac—Gastrointestinal pain—Doxorubicin—kidney cancer	4.65e-05	0.000208	CcSEcCtD
Etodolac—Urticaria—Doxorubicin—kidney cancer	4.51e-05	0.000202	CcSEcCtD
Etodolac—Body temperature increased—Doxorubicin—kidney cancer	4.49e-05	0.000201	CcSEcCtD
Etodolac—Abdominal pain—Doxorubicin—kidney cancer	4.49e-05	0.000201	CcSEcCtD
Etodolac—Hypersensitivity—Doxorubicin—kidney cancer	4.19e-05	0.000188	CcSEcCtD
Etodolac—Asthenia—Doxorubicin—kidney cancer	4.08e-05	0.000183	CcSEcCtD
Etodolac—Pruritus—Doxorubicin—kidney cancer	4.02e-05	0.00018	CcSEcCtD
Etodolac—Diarrhoea—Doxorubicin—kidney cancer	3.89e-05	0.000174	CcSEcCtD
Etodolac—Dizziness—Doxorubicin—kidney cancer	3.76e-05	0.000168	CcSEcCtD
Etodolac—Vomiting—Doxorubicin—kidney cancer	3.61e-05	0.000162	CcSEcCtD
Etodolac—Rash—Doxorubicin—kidney cancer	3.58e-05	0.00016	CcSEcCtD
Etodolac—Dermatitis—Doxorubicin—kidney cancer	3.58e-05	0.00016	CcSEcCtD
Etodolac—Headache—Doxorubicin—kidney cancer	3.56e-05	0.000159	CcSEcCtD
Etodolac—Nausea—Doxorubicin—kidney cancer	3.37e-05	0.000151	CcSEcCtD
Etodolac—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.43e-05	0.000255	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.41e-05	0.000253	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.4e-05	0.000252	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALDH1A1—kidney cancer	2.4e-05	0.000252	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ITPR2—kidney cancer	2.39e-05	0.000251	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TP53—kidney cancer	2.39e-05	0.00025	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.38e-05	0.00025	CbGpPWpGaD
Etodolac—RXRA—Metabolism—SCARB1—kidney cancer	2.37e-05	0.000249	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS1—kidney cancer	2.35e-05	0.000246	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—BCHE—kidney cancer	2.34e-05	0.000245	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—RAF1—kidney cancer	2.34e-05	0.000245	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—RELA—kidney cancer	2.33e-05	0.000244	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CCBL1—kidney cancer	2.32e-05	0.000244	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—ERBB2—kidney cancer	2.31e-05	0.000243	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—SLC5A5—kidney cancer	2.31e-05	0.000242	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SLC5A3—kidney cancer	2.3e-05	0.000242	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PGK1—kidney cancer	2.3e-05	0.000242	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PSMD7—kidney cancer	2.3e-05	0.000242	CbGpPWpGaD
Etodolac—ALB—Metabolism—APRT—kidney cancer	2.29e-05	0.00024	CbGpPWpGaD
Etodolac—ALB—Metabolism—FH—kidney cancer	2.29e-05	0.00024	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IFNA1—kidney cancer	2.27e-05	0.000238	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—LDHB—kidney cancer	2.26e-05	0.000237	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.24e-05	0.000234	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—SLC2A1—kidney cancer	2.23e-05	0.000234	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.21e-05	0.000231	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GSTP1—kidney cancer	2.19e-05	0.00023	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTT1—kidney cancer	2.18e-05	0.000229	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ACHE—kidney cancer	2.18e-05	0.000229	CbGpPWpGaD
Etodolac—RXRA—Metabolism—BCHE—kidney cancer	2.18e-05	0.000229	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—CDKN2B—kidney cancer	2.16e-05	0.000227	CbGpPWpGaD
Etodolac—RXRA—Metabolism—SLC5A5—kidney cancer	2.16e-05	0.000226	CbGpPWpGaD
Etodolac—ALB—Metabolism—GPC3—kidney cancer	2.15e-05	0.000226	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.15e-05	0.000225	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IFNA2—kidney cancer	2.11e-05	0.000221	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.1e-05	0.00022	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.1e-05	0.00022	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CRABP1—kidney cancer	2.1e-05	0.00022	CbGpPWpGaD
Etodolac—ALB—Metabolism—CA2—kidney cancer	2.09e-05	0.000219	CbGpPWpGaD
Etodolac—RXRA—Metabolism—SLC2A1—kidney cancer	2.08e-05	0.000218	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ABCB1—kidney cancer	2.07e-05	0.000217	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SCARB1—kidney cancer	2.07e-05	0.000217	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS1—kidney cancer	2.04e-05	0.000215	CbGpPWpGaD
Etodolac—PTGS2—Disease—RPL14—kidney cancer	2.04e-05	0.000215	CbGpPWpGaD
Etodolac—ALB—Metabolism—ALAD—kidney cancer	2.04e-05	0.000214	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.03e-05	0.000213	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	2.03e-05	0.000213	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.03e-05	0.000213	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—CTNNB1—kidney cancer	2.02e-05	0.000212	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.02e-05	0.000212	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PPAT—kidney cancer	2.01e-05	0.000211	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.01e-05	0.000211	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GSTM1—kidney cancer	2.01e-05	0.000211	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PSMD7—kidney cancer	2.01e-05	0.00021	CbGpPWpGaD
Etodolac—ALB—Metabolism—ST3GAL2—kidney cancer	1.99e-05	0.000209	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.99e-05	0.000209	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—RAF1—kidney cancer	1.99e-05	0.000208	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.98e-05	0.000207	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.97e-05	0.000206	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CA9—kidney cancer	1.96e-05	0.000206	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ITPR2—kidney cancer	1.95e-05	0.000205	CbGpPWpGaD
Etodolac—ALB—Metabolism—ALDH1A1—kidney cancer	1.94e-05	0.000204	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.93e-05	0.000203	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.91e-05	0.000201	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CYP1A1—kidney cancer	1.91e-05	0.0002	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—BCHE—kidney cancer	1.9e-05	0.000199	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IGF2—kidney cancer	1.9e-05	0.000199	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SLC5A5—kidney cancer	1.88e-05	0.000197	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APRT—kidney cancer	1.87e-05	0.000196	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—FH—kidney cancer	1.87e-05	0.000196	CbGpPWpGaD
Etodolac—ALB—Metabolism—PGK1—kidney cancer	1.86e-05	0.000196	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC5A3—kidney cancer	1.86e-05	0.000196	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GSTP1—kidney cancer	1.86e-05	0.000195	CbGpPWpGaD
Etodolac—PTGS2—Disease—ITPR2—kidney cancer	1.85e-05	0.000194	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.83e-05	0.000192	CbGpPWpGaD
Etodolac—ALB—Metabolism—LDHB—kidney cancer	1.83e-05	0.000192	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.83e-05	0.000192	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	1.82e-05	0.000191	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SLC2A1—kidney cancer	1.81e-05	0.00019	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.8e-05	0.000189	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—VEGFA—kidney cancer	1.78e-05	0.000187	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTT1—kidney cancer	1.78e-05	0.000187	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ACHE—kidney cancer	1.78e-05	0.000187	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ABCB1—kidney cancer	1.76e-05	0.000185	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.76e-05	0.000185	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GPC3—kidney cancer	1.76e-05	0.000185	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.76e-05	0.000185	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.74e-05	0.000183	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—MYC—kidney cancer	1.74e-05	0.000183	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GSTP1—kidney cancer	1.74e-05	0.000182	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CA2—kidney cancer	1.71e-05	0.00018	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GSTM1—kidney cancer	1.71e-05	0.000179	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MAPK3—kidney cancer	1.69e-05	0.000177	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SCARB1—kidney cancer	1.68e-05	0.000177	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.68e-05	0.000176	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALAD—kidney cancer	1.67e-05	0.000175	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CRABP1—kidney cancer	1.67e-05	0.000175	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ABCB1—kidney cancer	1.64e-05	0.000172	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PSMD7—kidney cancer	1.63e-05	0.000172	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.63e-05	0.000171	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.62e-05	0.00017	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP1A1—kidney cancer	1.62e-05	0.00017	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MAPK1—kidney cancer	1.6e-05	0.000168	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.6e-05	0.000168	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GSTM1—kidney cancer	1.6e-05	0.000167	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.59e-05	0.000167	CbGpPWpGaD
Etodolac—ALB—Metabolism—CA9—kidney cancer	1.59e-05	0.000166	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—BCHE—kidney cancer	1.55e-05	0.000163	CbGpPWpGaD
Etodolac—PTGS2—Disease—PSMD7—kidney cancer	1.55e-05	0.000163	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.55e-05	0.000163	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ITPR2—kidney cancer	1.55e-05	0.000162	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.55e-05	0.000162	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.53e-05	0.000161	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SLC5A5—kidney cancer	1.53e-05	0.000161	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PGK1—kidney cancer	1.53e-05	0.00016	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.53e-05	0.00016	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—KRAS—kidney cancer	1.51e-05	0.000159	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTP1—kidney cancer	1.51e-05	0.000159	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP1A1—kidney cancer	1.51e-05	0.000159	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LDHB—kidney cancer	1.5e-05	0.000157	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SLC2A1—kidney cancer	1.48e-05	0.000155	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.46e-05	0.000153	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.43e-05	0.00015	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ABCB1—kidney cancer	1.43e-05	0.00015	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.43e-05	0.00015	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—POMC—kidney cancer	1.42e-05	0.000149	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ACHE—kidney cancer	1.41e-05	0.000148	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTT1—kidney cancer	1.41e-05	0.000148	CbGpPWpGaD
Etodolac—PTGS2—Disease—SLC2A1—kidney cancer	1.4e-05	0.000147	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.39e-05	0.000146	CbGpPWpGaD
Etodolac—PTGS2—Disease—JUNB—kidney cancer	1.39e-05	0.000146	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTM1—kidney cancer	1.39e-05	0.000146	CbGpPWpGaD
Etodolac—ALB—Metabolism—CRABP1—kidney cancer	1.35e-05	0.000141	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SCARB1—kidney cancer	1.34e-05	0.00014	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PTGS1—kidney cancer	1.32e-05	0.000139	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP1A1—kidney cancer	1.32e-05	0.000138	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PSMD7—kidney cancer	1.3e-05	0.000136	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CA9—kidney cancer	1.3e-05	0.000136	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.27e-05	0.000133	CbGpPWpGaD
Etodolac—ALB—Metabolism—ITPR2—kidney cancer	1.25e-05	0.000131	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.25e-05	0.000131	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.24e-05	0.00013	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTP1—kidney cancer	1.23e-05	0.000129	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—BCHE—kidney cancer	1.23e-05	0.000129	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SLC5A5—kidney cancer	1.22e-05	0.000128	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—POMC—kidney cancer	1.21e-05	0.000127	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.21e-05	0.000127	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SLC2A1—kidney cancer	1.17e-05	0.000123	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ABCB1—kidney cancer	1.17e-05	0.000122	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.16e-05	0.000121	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTT1—kidney cancer	1.14e-05	0.00012	CbGpPWpGaD
Etodolac—ALB—Metabolism—ACHE—kidney cancer	1.14e-05	0.00012	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—kidney cancer	1.13e-05	0.000119	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTM1—kidney cancer	1.13e-05	0.000119	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN2B—kidney cancer	1.13e-05	0.000119	CbGpPWpGaD
Etodolac—RXRA—Metabolism—POMC—kidney cancer	1.13e-05	0.000118	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CRABP1—kidney cancer	1.1e-05	0.000116	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.08e-05	0.000114	CbGpPWpGaD
Etodolac—ALB—Metabolism—SCARB1—kidney cancer	1.08e-05	0.000113	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP1A1—kidney cancer	1.07e-05	0.000113	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS1—kidney cancer	1.07e-05	0.000112	CbGpPWpGaD
Etodolac—ALB—Metabolism—PSMD7—kidney cancer	1.05e-05	0.00011	CbGpPWpGaD
Etodolac—ALB—Hemostasis—RAF1—kidney cancer	1.05e-05	0.00011	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ITPR2—kidney cancer	1.03e-05	0.000108	CbGpPWpGaD
Etodolac—ALB—Metabolism—BCHE—kidney cancer	9.95e-06	0.000104	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.93e-06	0.000104	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTEN—kidney cancer	9.89e-06	0.000104	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC5A5—kidney cancer	9.83e-06	0.000103	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—POMC—kidney cancer	9.82e-06	0.000103	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTP1—kidney cancer	9.79e-06	0.000103	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—kidney cancer	9.64e-06	0.000101	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC2A1—kidney cancer	9.5e-06	9.96e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.45e-06	9.92e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IL2—kidney cancer	9.38e-06	9.84e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ACHE—kidney cancer	9.35e-06	9.81e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTT1—kidney cancer	9.35e-06	9.81e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ABCB1—kidney cancer	9.27e-06	9.72e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.21e-06	9.67e-05	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	9.06e-06	9.5e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HIF1A—kidney cancer	9.05e-06	9.5e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—TSC2—kidney cancer	9.03e-06	9.47e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTM1—kidney cancer	9e-06	9.44e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—kidney cancer	9e-06	9.44e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SCARB1—kidney cancer	8.85e-06	9.29e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.83e-06	9.26e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS1—kidney cancer	8.76e-06	9.19e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MAPK3—kidney cancer	8.62e-06	9.04e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PSMD7—kidney cancer	8.59e-06	9.02e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP1A1—kidney cancer	8.53e-06	8.95e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTEN—kidney cancer	8.41e-06	8.82e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MYC—kidney cancer	8.38e-06	8.8e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—BCHE—kidney cancer	8.15e-06	8.55e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC5A5—kidney cancer	8.05e-06	8.44e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.03e-06	8.43e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—POMC—kidney cancer	8.01e-06	8.4e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—KIT—kidney cancer	7.98e-06	8.37e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—APC—kidney cancer	7.98e-06	8.37e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—kidney cancer	7.97e-06	8.36e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTP1—kidney cancer	7.92e-06	8.31e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTEN—kidney cancer	7.85e-06	8.23e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—kidney cancer	7.84e-06	8.22e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC2A1—kidney cancer	7.77e-06	8.15e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.54e-06	7.91e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MAPK3—kidney cancer	7.54e-06	7.91e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—BRAF—kidney cancer	7.5e-06	7.87e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ABCB1—kidney cancer	7.5e-06	7.87e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTM1—kidney cancer	7.28e-06	7.64e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MAPK1—kidney cancer	7.17e-06	7.53e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.01e-06	7.35e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CA—kidney cancer	6.98e-06	7.32e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP1A1—kidney cancer	6.9e-06	7.24e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTEN—kidney cancer	6.83e-06	7.17e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—KRAS—kidney cancer	6.78e-06	7.11e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.58e-06	6.9e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTP1—kidney cancer	6.48e-06	6.8e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—kidney cancer	6.39e-06	6.7e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—POMC—kidney cancer	6.36e-06	6.67e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—RAF1—kidney cancer	6.26e-06	6.57e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CA—kidney cancer	6.23e-06	6.53e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB2—kidney cancer	6.19e-06	6.5e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ABCB1—kidney cancer	6.14e-06	6.44e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MTOR—kidney cancer	6.11e-06	6.41e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD4—kidney cancer	6.1e-06	6.4e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—kidney cancer	6.02e-06	6.32e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTM1—kidney cancer	5.96e-06	6.25e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CA—kidney cancer	5.93e-06	6.23e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN1B—kidney cancer	5.74e-06	6.02e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.67e-06	5.95e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP1A1—kidney cancer	5.65e-06	5.92e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTEN—kidney cancer	5.57e-06	5.85e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CA—kidney cancer	5.53e-06	5.81e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CTNNB1—kidney cancer	5.42e-06	5.68e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PTEN—kidney cancer	5.28e-06	5.54e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—POMC—kidney cancer	5.14e-06	5.4e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CA—kidney cancer	4.82e-06	5.06e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.64e-06	4.87e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAPK3—kidney cancer	4.51e-06	4.73e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PTEN—kidney cancer	4.42e-06	4.64e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MYC—kidney cancer	4.39e-06	4.6e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAPK1—kidney cancer	4.29e-06	4.5e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—POMC—kidney cancer	4.21e-06	4.42e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—kidney cancer	4.1e-06	4.3e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—KRAS—kidney cancer	4.06e-06	4.25e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CA—kidney cancer	3.93e-06	4.12e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CA—kidney cancer	3.73e-06	3.91e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTEN—kidney cancer	3.58e-06	3.75e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—kidney cancer	3.36e-06	3.52e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CA—kidney cancer	3.12e-06	3.27e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTEN—kidney cancer	2.93e-06	3.07e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CA—kidney cancer	2.52e-06	2.65e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.07e-06	2.17e-05	CbGpPWpGaD
